Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.
about
The role of TREX in gene expression and diseaseHow sleep and wakefulness influence circadian rhythmicity: effects of insufficient and mistimed sleep on the animal and human transcriptomeExploiting human and mouse transcriptomic data: Identification of circadian genes and pathways influencing health.Mutated Chromatin Regulatory Factors as Tumor Drivers in CancerMolecular mechanisms of MLL-associated leukemia.Epigenetic modifiers in normal and malignant hematopoiesis.Histone H3K4 trimethylation: dynamic interplay with pre-mRNA splicing.Mutation of cancer driver MLL2 results in transcription stress and genome instability.Distinct functions of histone H3, lysine 4 methyltransferases in normal and malignant hematopoiesis.SET/MLL family proteins in hematopoiesis and leukemia.Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old.Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.Controlled inhibition of methyltransferases using photoswitchable peptidomimetics: towards an epigenetic regulation of leukemia.The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability.Quantitative proteomic analysis of EZH2 inhibition in acute myeloid leukemia reveals the targets and pathways that precede the induction of cell death.Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.PD-L1 Expression in Pancreatic Cancer.WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage.The H3K4 methyltransferase Setd1b is essential for hematopoietic stem and progenitor cell homeostasis in mice.Turning Stem Cells Bad: Generation of Clinically Relevant Models of Human Acute Myeloid Leukemia through Gene Delivery- or Genome Editing-Based Approaches
P2860
Q28078160-EBB7D456-D055-494B-A0C1-BDC471CB8653Q28081994-AB407815-7FCC-4085-93E9-71BFB21352C8Q30910326-1AC901FA-9FE7-4F1A-9C09-A75170401DAEQ37592666-7B836AF2-9B02-47C4-ABDA-FE0A883D8387Q38379210-3D379F2B-5575-4E85-8297-46B9525B0C7EQ38459868-49CB089F-1618-4904-AD46-0CB0B019766BQ38583533-771E466E-BF1F-4EB8-89E5-99C2460EFF1CQ38586777-1FDB4B8D-375A-40BD-B6B7-D9EB5988682BQ38855791-F2306275-D013-4A0C-ABA0-9ADBC4F692FDQ38994704-F40E69D5-A7A4-4C14-A902-C2A28ABDCF21Q39129029-B06D1FBD-6D4E-42DE-903C-4EE11E740A77Q42260284-BC976052-D308-4B8B-97F8-2BC2CAD2C0ECQ42365675-847B2D16-E65A-4C7C-9BEA-F79438C6C47AQ47159993-39EFA21E-A6B6-48EB-B39A-13CB619CB1F0Q48226907-9E2C9E4D-9CFF-49C6-ACC0-64DFBAC5F673Q50196157-2B9305E4-81D9-4D7F-B2BC-963A78546114Q53790730-118EBFB0-129E-42B3-9B18-FC558140C7EEQ55427338-718CD598-65FC-4742-841D-5B26D86042B0Q55437673-88B5FC60-350D-4AB9-86C3-2664B015D6CFQ58692793-47A5D517-CB2C-40A8-9DD1-B7C1F156DB62
P2860
Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Two decades of leukemia oncopr ...... etic deregulation in leukemia.
@ast
Two decades of leukemia oncopr ...... etic deregulation in leukemia.
@en
type
label
Two decades of leukemia oncopr ...... etic deregulation in leukemia.
@ast
Two decades of leukemia oncopr ...... etic deregulation in leukemia.
@en
prefLabel
Two decades of leukemia oncopr ...... etic deregulation in leukemia.
@ast
Two decades of leukemia oncopr ...... etic deregulation in leukemia.
@en
P2860
P1476
Two decades of leukemia oncopr ...... netic deregulation in leukemia
@en
P2093
P2860
P304
P356
10.1016/J.EXPHEM.2014.09.006
P50
P577
2014-09-28T00:00:00Z